| Bioactivity | LY433771 (LSN433771) (Compound 8) is a type X secretory phospholipase A2 (sPLA2) inhibitor with an IC50 value of 3 nM, which can be used in the study of cardiovascular diseases[1][2]. |
| CAS | 220862-64-6 |
| Formula | C22H24N2O4 |
| Molar Mass | 380.44 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Takashi Ono, et al. V TYPE AND/OR X TYPE sPLA2 INHIBITORS. Patent, WO2001026653, 2001-04-19. [2]. Magrioti V, Kokotos G. Phospholipase A2 inhibitors as potential therapeutic agents for the treatment of inflammatory diseases[J]. Expert opinion on therapeutic patents, 2010, 20(1): 1-18. |